Table 3:
Predicted and observed mortalities by EuroSCORE II and STS risk levels for the entire patient cohort
EuroSCORE II | Patients (deaths) | Observed mortality rate (95% CI) | Predicted mortality rate (95% CI) | Recalibration | P-value |
---|---|---|---|---|---|
Low risk | 143 (4) | 2.1 (0.1–5.5) | 0.9 (0.87–0.91) | 3.14 | 0.00 |
Medium risk | 143 (6) | 4.2 (0.9–7.5) | 1.4 (1.4–1.5) | 2.93 | |
High risk | 142 (24) | 16.9 (10.7–23.1) | 2.8 (2.6–3.1) | 5.94 | |
Total | 428 (34) | 7.9 (5.4–10.5) | 1.7 (1.6–1.8) | ||
STS risk model | |||||
Low risk | 143 (10) | 7.0 (2.8–11.2) | 1.8 (1.7–1.9) | 3.88 | 0.10 |
Medium risk | 143 (6) | 4.2 (0.9–7.5) | 4.9 (4.8–5.1) | 0.85 | |
High risk | 142 (18) | 12.7 (7.1–18.2) | 10.7 (10.1–11.4) | 1.18 | |
Total | 428 (34) | 7.9 (5.4–10.5) | 5.8 (5.4–6.2) |
STS: Society of Thoracic Surgeons.